NCT05258526 Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study) Status UNKNOWN Phase NA
NCT05253053 To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05252806 Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer Status UNKNOWN Phase N/A
NCT05252390 NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05249712 Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer Status RECRUITING Phase PHASE2
NCT05248282 Clinical Validation of the Prognostic Value of the PrTS on Prostate Cancer Patients Status UNKNOWN Phase N/A
NCT05246774 Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer Status UNKNOWN Phase N/A
NCT05245435 Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer Status WITHDRAWN Phase NA
NCT05245006 PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05239377 MiProstate - Information Hub for the Prostate Cancer Care Flow Status COMPLETED Phase N/A
NCT05232578 Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness Status NOT_YET_RECRUITING Phase PHASE3
NCT05231915 Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique Status COMPLETED Phase NA
NCT05230251 Radioligand fOr locAl raDiorecurrent proStaTe cancER Status COMPLETED Phase PHASE1/PHASE2
NCT05224869 Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer Status TERMINATED Phase NA
NCT05223218 Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study Status UNKNOWN Phase N/A
NCT05215574 Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05212857 Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer Status UNKNOWN Phase PHASE2